Venture Life Group PLC

Research Venture Life Group PLC (VLG) on Bullrun: market cap GBX 7.89B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is GBX 7.89B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024GBP 26.59M-GBP 314.00KGBP 8.34M45.8%0GBP 3.05MGBP 23.86MGBP 75.41M
FY2023GBP 22.37MGBP 921.00KGBP 7.99M41.6%0.01GBP 5.62MGBP 24.39MGBP 76.25M
FY2022GBP 43.98MGBP 520.00KGBP 1.36M40.2%0GBP 5.63MGBP 26.85MGBP 75.66M
FY2021GBP 32.76MGBP 2.40M-GBP 2.66M39.6%0.02GBP 5.24MGBP 12.73MGBP 73.16M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-29GBX 7.89Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 GBX.

About Venture Life Group PLC

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand;

Related stock research

Other Consumer Defensive stocks

Frequently asked questions

What is Venture Life Group PLC's market cap?

Venture Life Group PLC's market capitalization is GBX 7.89B.

What does Venture Life Group PLC do?

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids.